TABLE 3.
Final parameter estimates for the TTE model
| Parameter | Parameter estimate | RSE (%) | 95% CI |
|---|---|---|---|
| Baseline hazard rate λ (per 100 000 subjects) [day −1 ] | 7.78 | (6%) | 6.86‐8.70 |
| Hazard ratios | |||
| Tamsulosin | 1 | … | … |
| Dutasteride | 0.432 | (7%) | 0.352‐0.512 |
| Combination | 0.336 | (7%) | 0.249‐0.423 |
| Baseline IPSS | 1.04 | (19%) | 1.022‐1.050 |
| Baseline PSA | 1.08 | (24%) | 1.041‐1.120 |
| Baseline prostate volume | 1.01 | (14%) | 1.007‐1.012 |
| Baseline maximum urinary flow | 0.91 | (14%) | 0.889‐0.935 |
Abbreviations: 95% CI, 95%‐confidence interval; IPSS, International Prostate Symptom Score; PSA, prostate‐specific antigen; RSE, relative standard error.